Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20050271742 A1
Publication typeApplication
Application numberUS 11/129,066
Publication dateDec 8, 2005
Filing dateMay 13, 2005
Priority dateJul 14, 1999
Also published asUS7094282, US7214265, US7258734, US7976874, US20040031420, US20050268819, US20050271740, US20050271741
Publication number11129066, 129066, US 2005/0271742 A1, US 2005/271742 A1, US 20050271742 A1, US 20050271742A1, US 2005271742 A1, US 2005271742A1, US-A1-20050271742, US-A1-2005271742, US2005/0271742A1, US2005/271742A1, US20050271742 A1, US20050271742A1, US2005271742 A1, US2005271742A1
InventorsJiin-Huey Chern Lin, Chien-Ping Ju, Wen-Cheng Chen
Original AssigneeCalcitec, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Injectable calcium phosphate cements and the preparation and use thereof
US 20050271742 A1
Abstract
A calcium phosphate cement suitable for use in dental and bone prosthesis is disclosed, which include calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said calcium phosphate particles on their surfaces have whiskers or fine crystals having a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
Images(11)
Previous page
Next page
Claims(28)
1-45. (canceled)
46. A system for repairing a defect in a tooth or in a bone of a patient comprising:
calcium phosphate cement particles that are non-dispersive in an aqueous solution, wherein the diameter of the calcium phosphate cement particles is from about 0.05 microns to about 100 microns, wherein at least a portion of the calcium phosphate cement particles have surface whiskers comprising basic calcium phosphate crystals, and wherein the surface whiskers have a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm;
an aqueous solution, the aqueous solution comprising a hardening promoter; and
an injector configured to inject a paste formed by contacting the calcium phosphate cement particles with the aqueous solution into the defect in the bone or in the tooth.
47. The system of claim 46, wherein the calcium phosphate cement particles comprise calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, tetracalcium phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, apatite and hydroxyapatite, or a mixture thereof.
48. The system of claim 46, wherein the calcium phosphate cement particles comprise dicalcium phosphate anhydrous, tetracalcium phosphate, tricalcium phosphate, or mixtures thereof.
49. The system of claim 46, wherein the aqueous solution further comprises a growth factor, a bone morphology protein, a pharmaceutical carrier, or mixtures thereof.
50. The system of claim 46, further comprising a growth factor, a bone morphology protein, a pharmaceutical carrier, or mixtures thereof.
51. The system of claim 46, wherein the hardening promoter comprises phosphate ions, calcium ions, fluorine ions, or mixtures thereof.
52. The system of claim 46, wherein hardening-promoter comprises about 1 mM to about 3 M phosphate ions.
53. The system of claim 46, wherein the pH of the aqueous solution is at least about 6.0.
54. The system of claim 46, wherein the calcium phosphate cement particles have a diameter ranging from about 0.5 microns to about 50 microns, and wherein the whiskers or fine crystals have a length ranging from 10 nm to about 700 nm.
55. The system of claim 46, wherein the calcium phosphate cement particles have a calcium to phosphate molar ratio ranging from about 0.5 to about 2.5.
56. The system of claim 46, wherein the calcium phosphate cement particles have a calcium to phosphate molar ratio ranging from about 0.8 to about 2.3.
57. The system of claim 46, wherein the calcium phosphate cement particles have a calcium to phosphate molar ratio ranging from about 1.0 to about 2.2.
58. A method of repairing a defect in a bone of a patient comprising:
contacting calcium phosphate cement particles with an aqueous solution comprising a hardening-promoter to form a non-dispersive, injectable paste;
shaping the paste, wherein the shaped paste is substantially complementary to the defect in the bone; and
implanting the shaped paste into the bone to repair the defect;
wherein the average diameter of the calcium phosphate cement particles is from about 0.05 microns to about 100 microns, wherein at least a portion of the calcium phosphate particles have surface whiskers comprising basic calcium phosphate crystals, and wherein the surface whiskers have a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
59. The method of claim 58, wherein the calcium phosphate cement particles comprise calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, tetracalcium phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, apatite and hydroxyapatite, or mixtures thereof.
60. The method of claim 58, wherein the calcium phosphate cement particles comprise dicalcium phosphate anhydrous, tetracalcium phosphate, tricalcium phosphate, or mixtures thereof.
61. The method of claim 58, wherein the paste further comprises a growth factor, a bone morphology protein, a pharmaceutical carrier, or mixtures thereof.
62. The method of claim 58, wherein the hardening-promoter comprises phosphate ions, calcium ions, fluorine ions, or mixtures thereof.
63. The method of claim 58, wherein the aqueous solution comprises about 1 mM to about 3 M of the hardening promoter.
64. The method of claim 58, wherein hardening-promoter comprises phosphate ions.
65. The method of claim 58, wherein the pH of the aqueous solution is at least about 6.0.
66. The method of claim 58, wherein the calcium phosphate cement particles have a diameter ranging from about 0.5 microns to about 50 microns.
67. The method of claim 58, wherein the whiskers or fine crystals have a length ranging from about 10 nm to about 700 nm.
68. The method of claim 58, wherein the calcium phosphate cement particles have a calcium to phosphate molar ratio ranging from about 0.5 to about 2.5.
69. The method of claim 58, wherein the calcium phosphate particles have a calcium to phosphate molar ratio ranging from about 0.8 to about 2.3.
70. The method of claim 58, wherein the calcium phosphate particles have a calcium to phosphate molar ratio ranging from about 1.0 to about 2.2.
71. The method of claim 58, wherein the setting time of the injectable paste is adapted to be less than about 30 minutes.
72. The method of claim 58, wherein the working time of the injectable paste is adapted to be less than about 25 minutes.
Description
    RELATED APPLICATION
  • [0001]
    This application is a continuation-in-part and claims the benefit of priority under 35 USC 120 of U.S. application Ser. No. 09/615,384, filed Jul. 13, 2000. The disclosure of the prior application is considered part of and is incorporated by reference in the disclosure of this application.
  • BACKGROUND OF THE INVENTION
  • [0002]
    1. Field of the Invention
  • [0003]
    The present invention is related to a calcium phosphate cement, and in particular a fast-setting calcium phosphate cement, for use in dental and bone prosthesis.
  • [0004]
    2. Description of the Related Art
  • [0005]
    A calcium phosphate cement (abbreviated as CPC) has been widely used as an implant or filling material in dental and bone prosthesis, and its technical details can be found in many patents, for examples U.S. Pat. Nos. 4,959,104; 5,092,888; 5,180,426; 5,262,166; 5,336,264; 5,525,148; 5,053,212; 5,149,368; 5,342,441; 5,503,164; 5,542,973; 5,545,254; 5,695,729 and 5,814,681. In general, the prior art calcium phosphate cements suffer one or more drawbacks as follows: 1) additives having a relatively poor bioactivity being required; 2) a complicated preparation process; 3) an undesired setting time or working time of CPC, which are difficult to be adjusted; 4) not capable of being set to a desired shape in water, blood or body fluid; and 5) poor initial strength after setting of the CPC.
  • SUMMARY OF THE INVENTION
  • [0006]
    An object of the present invention is to provide a calcium phosphate cement.
  • [0007]
    Another object of the present invention is to provide a calcium phosphate cement comprising particles having whiskers or fine crystals on surfaces of the particles. Still another object of the present invention is to provide a process for preparing a calcium phosphate cement.
  • [0008]
    A further object of the present invention is to provide a method of treating a born or a tooth having a defect in a patient by using a calcium phosphate cement.
  • [0009]
    In order to accomplish the above objects of the present invention a calcium phosphate cement prepared in accordance with the present invention comprises calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said calcium phosphate particles on their surfaces have whiskers or fine crystals having a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm. By adjusting the diameter of the calcium phosphate particles, the width and/or the length of the whiskers or fine crystals, the inventors of the present invention are able to adjust the working time and/or the setting time of the calcium phosphate cement of the present invention to conform to requirements for various purposes. Moreover, the calcium phosphate cement of the present invention is fast-setting, and is non-dispersive in water or an aqueous solution.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0010]
    FIG. 1 is a normalized particle amount (%) versus particle diameter (pm) plot showing a particle diameter distribution of a calcium phosphate cement (CPC) prepared in accordance with the following Example 6 of the present invention.
  • [0011]
    FIG. 2 is a scanning electron microscopy (SEM) micrograph of the calcium phosphate cement prepared in accordance with Example 6 of the present invention.
  • [0012]
    FIGS. 3 and 4 show the distributions of the lengths and the widths of the whiskers or fine crystals on surfaces of the calcium phosphate particles prepared in the following Example 6 of the present invention, respectively, which are determined directly from transmission electron microscopy (TEM).
  • [0013]
    FIGS. 5 a to 5 c are photographs showing a conventional CPC paste injected into water via a syringe at 3, 10 and 30 seconds after the conventional CPC paste being formed.
  • [0014]
    FIGS. 6 a to 6 c are photographs showing a CPC paste of the present invention injected into water via a syringe at 3, 10 and 30 seconds after the CPC paste being formed in accordance with the following Example 7.
  • [0015]
    FIGS. 7 a to 7 c are photographs showing two cylinders prepared by separately molding a conventional CPC paste and a CPC paste of the present invention prepared in the following Example 7, which were taken at 5, 20 and 60 seconds after the two cylinders being immersed in the water.
  • [0016]
    FIG. 8 is a TEM micrograph showing the calcium phosphate cement of the present invention prepared in the following Example 7.
  • [0017]
    FIG. 9 is a TEM micrograph showing the calcium phosphate cement of the present invention prepared in the following Example 7.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0018]
    A suitable process for preparing the calcium phosphate cement of the present invention comprises mixing a calcium phosphate powder or small pieces of calcium phosphate with a wetting agent, and controlling growth of whiskers or fine crystals on surfaces of said calcium phosphate powder or small pieces of calcium phosphate by an controlling treatment.
  • [0019]
    Suitable calcium phosphates for use as the calcium phosphate powder or small pieces of calcium phosphate in the present invention can be any known calcium phosphates such as calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, apatite, hydroxyapatite, a mixture thereof and an adduct thereof. Moreover, the shape of the calcium phosphate powder and the shape of the small pieces of calcium phosphate are not limited, which can be spherical or irregular; and the crystal structure thereof can be single crystal, polycrystal, mixed crystals, semi-crystal, or amorphous.
  • [0020]
    The process for preparing the calcium phosphate cement preferably further comprises grinding the resulting product from the controlling treatment to form calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said whiskers or fine crystals have a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
  • [0021]
    Said controlling treatment is a vacuuming treatment, an organic solvent treatment, a microwave treatment, a heating treatment, or any other treatments which can control growth of whiskers or fine crystals on surfaces of said calcium phosphate powder or small pieces of calcium phosphate.
  • [0022]
    Said wetting agent is used to wet the calcium phosphate powder or small pieces of calcium phosphate, and preferably is a diluted aqueous solution containing phosphoric acid or phosphate. The amount of said wetting agent mixed with the calcium phosphate powder or small pieces of calcium phosphate, in general, should be enough to wet substantially all the calcium phosphate powder or small pieces of calcium phosphate. However, it is not necessarily the case when said controlling treatment is the organic solvent treatment, where a water miscible organic solvent is added to the mixture of said wetting agent and said calcium phosphate powder or small pieces of calcium phosphate to form a paste for a subsequent processing step.
  • [0023]
    Preferably, said wetting agent is a diluted aqueous solution containing more than 20 ppm of phosphoric acid or phosphate, more preferably more than 50 ppm, and most preferably more than 100 ppm of phosphoric acid or phosphate.
  • [0024]
    Preferably, the process for preparing the calcium phosphate cement of the present invention comprises soaking said calcium phosphate powder or said small pieces of calcium phosphate with said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out (a) said heating treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate at a temperature higher than 45 C.; (b) said vacuuming treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate under vacuum; or (c) said microwave treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate by microwave heating. More preferably, the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate is well mixed to form a uniform mixture prior to being subjected to treatment (a), (b) or (c).
  • [0025]
    Alternatively, the process for preparing the calcium phosphate cement of the present invention comprises mixing said calcium phosphate powder or said small pieces of calcium phosphate with said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out said organic solvent treatment comprising mixing the mixture of said wetting agent and said calcium phosphate powder or small pieces of calcium phosphate with a water miscible organic solvent, and drying the resulting mixture under vacuum. Preferably, said organic solvent treatment is carried out while stirring, and more preferably, the mixture of said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate and said calcium phosphate powder or small pieces of calcium phosphate is well mixed prior to being subjected to said organic solvent treatment.
  • [0026]
    Preferably, said calcium phosphate particles of the calcium phosphate cement of the present invention have a diameter of 0.2 to 80 microns, and more preferably 0.5 to 50 microns.
  • [0027]
    The width of a whisker means an average value of lateral cross-sectional diameters of the whisker, and the width of a fine crystal means an average value of the first 30% of the diameters of the fine crystal, which are shorter than the other 70% thereof. The length of a fine crystal means an average value of the last 30% of the diameters of the fine crystal, which are longer than the other 70% thereof.
  • [0028]
    Preferably, said whiskers or fine crystals have a width ranging from 2 to 70 nm and a length ranging from 5 to 800 nm, and more preferably a length ranging from 10 to 700 nm.
  • [0029]
    Preferably, said calcium phosphate particles have a molar ratio of calcium to phosphate ranging from 0.5 to 2.5, more preferably 0.8 to 2.3, and most preferably 1.0 to 2.2.
  • [0030]
    The calcium phosphate cement of the present invention is biocompatible and a paste made therefrom is non-dispersive in water, which has a working time from several minutes to hours and a setting time from a few minutes to hours. Consequently, the calcium phosphate cement of the present invention is extremely suitable for use as an implant or filling material in dental or bone prosthesis, where the paste must contact water, blood or body fluid. Particularly, the paste made from the calcium phosphate cement of the present invention is able to be directly injected into a bone defect or cavity as an implant or filling material.
  • [0031]
    The present invention also discloses a method of treating a born or a tooth having a defect in a patient, comprising mixing the calcium phosphate cement of the present invention and a hardening-promoter-containing aqueous solution to form a paste, and a) injecting said paste into a bone defect or cavity of said patient or b) shaping said paste and implanting the resulting shaped paste into a bone defect or cavity of said patient.
  • [0032]
    In the method of the present invention, said calcium phosphate cement may further comprise a growth factor, a bone morphology protein or a pharmaceutical carrier, or said hardening-promoter-containing aqueous solution further comprises a growth factor, a bone morphology protein or a pharmaceutical carrier.
  • [0033]
    Said hardening-promoter-containing aqueous solution can be an aqueous solution comprising any known compounds or compositions which enable the solidification of calcium phosphate, for examples phosphates, calcium salts, and fluorides. That is said hardening-promoter-containing aqueous solution may be an aqueous solution comprising phosphate ions, calcium ions, fluorine ions, or phosphate ions together with fluorine ions as a hardening promoter.
  • [0034]
    The content of said hardening promoter in said hardening-promoter-containing aqueous solution has no special limitation, but preferably ranges from 1 mM to 3 M, and more preferably from 10 mM to 1 M.
  • [0035]
    The mixing ratio of the calcium phosphate cement of the present invention and said hardening-promoter-containing aqueous solution is not restricted to any particular ranges; however, the amount of said hardening-promoter-containing aqueous solution mixed should be sufficient to provide substantial wetting of the calcium phosphate cement of the present invention. It should be noted that more water can be supplied in-situ from saliva or body fluid, when the paste is injected or implanted into the bone defect or cavity. Further, the content of said hardening promoter in said hardening-promoter-containing aqueous solution should be adjusted to a higher level corresponding to a less amount of said hardening-promoter-containing aqueous solution being mixed.
  • EXAMPLE 1 Heating Treatment
  • [0036]
    5 g of Ca(H2PO4)2.H2O powder and 1.6 ml of 25 mM phosphoric acid aqueous solution were mixed, and stirred for one minute. The resulting mixture was placed into an oven at 50 C. for 15 minutes, and the resulting dried mixture was mechanically ground for 20 minutes to fine particles after being removed from the oven. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The setting time is the time required when a 1 mm diameter pin with a load of pounds can be inserted only 1 mm deep into the surface of the paste. The working time is the time after which the paste is too viscous to be stirred. The working time of the paste of this example is 30 minutes and the setting time thereof is one hour.
  • [0037]
    The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
  • EXAMPLE 2 Vacuuming Treatment
  • [0038]
    5 g of CaHPO4 (DCPA) powder and 1.2 ml of 25 mM phosphoric acid aqueous solution were mixed, and stirred for one minute. The resulting mixture was placed in a vacuum environment of −100 Pa for 30 minutes, and the resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 20.5 minutes and the setting time thereof is 24 minutes.
  • [0039]
    The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
  • EXAMPLE 3 Organic Solvent Treatment
  • [0040]
    5 g of CaHPO4 (DCPA) powder and 1.6 ml of 25 mM phosphoric acid aqueous solution were mixed, and stirred for one minute. To the resulting mixture 1.6 ml of acetone was added while stirring to form a paste followed by placing in a vacuum environment of −100 Pa for one hour, and the resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 20.0 minutes and the setting time thereof is 22.0 minutes.
  • [0041]
    The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
  • EXAMPLE 4 Microwave Treatment
  • [0042]
    3 g of a mixed powder of CaHPO4 (DCPA) and Ca4(PO4)2O (TTCP) in 1:1 molar ratio was mixed with 2.0 ml of 25 mM phosphoric acid aqueous solution, and the mixture was stirred for five minutes. The resulting mixture was placed in a microwave oven where it was heated under low power for five minutes. The resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.42 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 2.0 minutes and the setting time thereof is 4.0 minutes.
  • [0043]
    The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
  • EXAMPLE 5 Heating Treatment
  • [0044]
    5 g of a mixed powder of DCPA and TTCP in 1:1 molar ratio was mixed with 1.6 ml of 25 mM phosphoric acid aqueous solution, and the mixture was stirred for one minute. The resulting mixture was placed in a high temperature oven at 500 C. for five minutes. The resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 1.5 minutes and the setting time thereof is 2.5 minutes.
  • [0045]
    The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
  • EXAMPLE 6 Heating Treatment
  • [0046]
    5 g of a mixed powder of DCPA and TTCP in 1:1 molar ratio was mixed with 1.6 ml of 25 mM phosphoric acid aqueous solution, and the mixture was stirred for one minute. The resulting mixture was placed in a high temperature oven at 1000 C. for one minute. The resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 31 minutes and the setting time thereof is 35 minutes.
  • EXAMPLES 7-11
  • [0047]
    The procedures of Example 1 were repeated except that the Ca(H2PO4)2. H2O powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The heating treatments were carried out with conditions listed in Table 1. The performance is also listed in Table 1.
  • CONTROL EXAMPLE 1
  • [0048]
    1 g of a mixed powder of DCPA and TTCP in 1:1 mole and 0.4 ml of a diluted phosphoric acid aqueous solution having a pH of 1.96 were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The paste of this example can not set within hours. The performance is listed in Table 1.
  • EXAMPLE 12
  • [0049]
    The procedures of Example 2 were repeated except that the DCPA powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The performance is listed in Table 1.
  • EXAMPLE 13
  • [0050]
    The procedures of Example 3 were repeated except that the DCPA powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The performance is listed in Table 1.
  • EXAMPLE 14
  • [0051]
    The procedures of Example 4 were repeated except that the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The performance is listed in Table 1.
    TABLE 1
    Setting/working Dispersive
    Controlling treatment time (min) in Water
    Control Ex. 1 Yes
    Ex. 7  Heating, 50 C. 11.5/6.5  No
    Ex. 8  Heating, 100 C. 13.5/8.0  No
    Ex. 9  Heating, 150 C. 8.5/8.0 No
    Ex. 10 Heating, 500 C. 2.5/1.5 No
    Ex. 11 Heating, 1000 C. 35/31 No
    Ex. 12 Vacuuming 14.5/11.5 No
    Ex. 13 Organic solvent 17.5/16.5 No
    Ex. 14 Microwave 3.5/2.5 No
  • [0052]
    The pastes prepared in Control Example 1 and Example 7 were injected into water via a syringe at 3, 10 and 30 seconds after the paste being formed. The results are shown in FIGS. 5 a to 5 c and FIGS. 6 a to 6 c, respectively. It can be seen from FIGS. 5 a to 5 b that the paste prepared in Control Example 1 is dispersive in water. On the contrary, the paste prepared in Example 7 is non-dispersive as shown in FIGS. 6 a to 6 c.
  • [0053]
    Two cylinders were prepared by separately molding the pastes prepared in Control Example 1 and Example 7, and were then placed in water. FIGS. 7 a to 7 c show the pictures taken at 5, 20 and 60 seconds after the cylinders being immersed in the water, from which it can be seen that the left cylinder made from the paste prepared in Control Example 1 collapses, while the right cylinder made form the paste prepared in Example 7 remains almost intact.
  • [0054]
    It can be concluded from the results shown in FIGS. 5 a to 7 c that the paste prepared from the calcium phosphate cement of the present invention can be directly injected or implanted after being molded into a block into a cavity in a deformed tooth or bone.
  • [0055]
    Two samples of the calcium phosphate cement prepared in Example 7 were observed by transmission electron microscopy (TEM), and the two TEM pictures shown in FIGS. 8 and 9 indicate that there are whiskers on surfaces of calcium phosphate particles having different diameters of the calcium phosphate cement.
  • [0056]
    The calcium phosphate cement prepared in Example 6 has a particle diameter distribution shown in FIG. 1, which was determined by using particle size analyzer (Sald-2001, Shimadzu Co., Japan). The curve in FIG. 1 indicates that the particle diameters of the calcium phosphate cement prepared in Example 6 range from about 0.47 microns to 93.49 microns. FIG. 2 shows a scanning electron microscopy (SEM) micrograph of the calcium phosphate cement prepared in Example 6. Moreover, the lengths and the widths of the whiskers or fine crystals on surfaces of the calcium phosphate particles prepared in Example 6 were determined directly from TEM (JXA-840, JEOL Co., Japan), and the results are shown in FIGS. 3 and 4, respectively. As shown in FIGS. 3 and 4, the lengths and widths of the of the whiskers or fine crystals on surfaces of the calcium phosphate particles prepared in Example 6 range from 1 to 625 nm and 1 to 65 nm, respectively.
  • EXAMPLES 15-19
  • [0057]
    The procedures of Example 7 were repeated by using the calcium phosphate powders and the wetting solutions listed in Table 2. The performance is also listed in Table 2.
    TABLE 2
    Setting/ Dis-
    Calcium Heating working persive
    phosphate Wetting treat- time in
    powder* solution ment (min) water
    Ex. 15 TCP Acetic acid Yes  10/6.5 No
    Control TCP No Yes
    Ex. 2
    Ex. 16 TCP Acetic acid Yes 12.5/8.5  No
    Control TCP No Yes
    Ex. 3
    Ex. 17 TTCP + DCPA Phosphoric Yes 11/18 No
    acid
    Control TTCP + DCPA No Yes
    Ex. 4
    Ex. 18 TTCP + DCPA + Phosphoric Yes No
    TCP acid
    Control TTCP + DCPA + No Yes
    Ex. 5 TCP
    Ex. 19 DCPA + TCP Phosphoric Yes 29/24 No
    acid
    Control DCPA + TCP No Yes
    Ex. 6

    *TCP is anhydrous tricalcium phosphate.

    TTCP + DCPA is a mixed powder of TTCP and DCPA in 1:1 molar ratio.

    TTCP + DCPA + TCP is a mixed powder of TTCP + DCPA and TCP in 1:1 weight ratio.

    DCPA + TCP is a mixed powder of DCPA and TCP in 1:2 molar ratio.

    DCPA + TCP is a mixed powder of DCPA and TCP in 1:2 molar ratio.
  • CONTROL EXAMPLES 2-6
  • [0058]
    The procedures of Control Example 1 were repeated by using the calcium phosphate powders and the wetting solutions listed in Table 2. The performance is also listed in Table 2.
  • EXAMPLES 20-31
  • [0059]
    The procedures of Example 7 were repeated by using the wetting solutions having different pH values listed in Table 3. The performance is also listed in Table 3.
  • CONTROL EXAMPLES 7-14
  • [0060]
    The procedures of Control Example 1 were repeated by using the wetting solutions having different pH values listed in Table 3. The performance is also listed in Table 3.
    TABLE 3
    Heating Dispersive
    Wetting solution pH treatment in water
    Ex. 20 Phosphoric acid 0.56 Yes No
    Control Ex. 7 No Yes
    Ex. 21 Phosphoric acid 1.03 Yes No
    Ex. 22 Phosphoric acid 1.17 Yes No
    Ex. 23 Phosphoric acid 1.22 Yes No
    Ex. 24 Phosphoric acid 1.32 Yes No
    Ex. 25 Phosphoric acid 2.0 Yes No
    Control Ex. 8 No Yes
    Ex. 26 Acetic acid + sodium 7.0 Yes No
    carbonate
    Control Ex. 9 No Yes
    Ex. 27 Sodium hydroxide 9.5 Yes No
    Control Ex. 10 No Yes
    Ex. 28 Sodium hydroxide 12.55 Yes No
    Control Ex. 11 No Yes
    Ex. 29 Acetic acid 1.96 Yes No
    Control Ex. 12 No Yes
    Ex. 30 Ethanol Yes No
    Control Ex. 13 No Yes
    Ex. 31 Deionized water 7.0 Yes No
    Control Ex. 14 No Yes
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3679360 *Jun 26, 1970Jul 25, 1972NasaProcess for the preparation of brushite crystals
US4371484 *May 27, 1981Feb 1, 1983Mitsubishi Mining & Cement Co., Ltd.Process for making porous sintered body of calcium phosphate
US4481175 *Oct 21, 1983Nov 6, 1984Mitsui Toatsu Chemicals, Inc.Process for preparing apatite
US4518430 *Oct 6, 1983May 21, 1985American Dental Association Health FoundationDental resptorative cement pastes
US4612053 *May 9, 1985Sep 16, 1986American Dental Association Health FoundationCombinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements
US4623553 *Jun 4, 1985Nov 18, 1986Oscobal AgMethod of producing a bone substitute material
US4959104 *Dec 20, 1988Sep 25, 1990Mitsui Toatsu Chemicals, Inc.Self-hardenable material
US5017518 *Apr 18, 1990May 21, 1991Asahi Kogaku Kogyo K.K.Process for producing calcium phosphate ceramics having porous surface
US5053212 *Jul 27, 1990Oct 1, 1991Norian CorporationIntimate mixture of calcium and phosphate sources as precursor to hydroxyapatite
US5092888 *May 17, 1990Mar 3, 1992Tokuyama Soda Kabushiki KaishaHardening material
US5149368 *Jan 10, 1991Sep 22, 1992Liu Sung TsuenResorbable bioactive calcium phosphate cement
US5164187 *Apr 5, 1990Nov 17, 1992Norian CorporationHydroxyapatite prosthesis coatings
US5180426 *Nov 4, 1991Jan 19, 1993Asahi Kogaku Kogyo K.K.Composition for forming calcium phosphate type setting material and process for producing setting material
US5262166 *Apr 17, 1991Nov 16, 1993Lty Medical IncResorbable bioactive phosphate containing cements
US5336264 *Jul 23, 1992Aug 9, 1994Norian CorporationSitu prepared calcium phosphate composition and method
US5338356 *Oct 21, 1992Aug 16, 1994Mitsubishi Materials CorporationCalcium phosphate granular cement and method for producing same
US5342441 *Jun 22, 1992Aug 30, 1994Nitta Gelatin Inc.Biologically compatible hardening material for dental or medical applications
US5409982 *Jun 9, 1993Apr 25, 1995Osaka Cement Co. Ltd.Tetracalcium phosphate-based materials and process for their preparation
US5492768 *Apr 21, 1995Feb 20, 1996Kyocera CorporationPorous living body repairing member, and a method of imparting elasticity to it
US5496399 *Aug 23, 1994Mar 5, 1996Norian CorporationStorage stable calcium phosphate cements
US5503164 *Jan 28, 1994Apr 2, 1996Osteogenics, Inc.Device and method for repair of craniomaxillofacial bone defects including burr holes
US5522893 *Mar 12, 1993Jun 4, 1996American Dental Association Health FoundationCalcium phosphate hydroxyapatite precursor and methods for making and using the same
US5525148 *Sep 24, 1993Jun 11, 1996American Dental Association Health FoundationSelf-setting calcium phosphate cements and methods for preparing and using them
US5536575 *Dec 21, 1994Jul 16, 1996Osaka Cement Co., Ltd.Tetracalcium phosphate-based materials and processes for their preparation
US5542973 *Dec 9, 1994Aug 6, 1996The American Dental Association Health FoundationCalcium phosphate hydroxyapatite precursor and methods for making and using the same
US5545254 *Dec 9, 1994Aug 13, 1996The American Dental Association Health FoundationCalcium phosphate hydroxyapatite precursor and methods for making and using the same
US5550172 *Feb 7, 1995Aug 27, 1996Ethicon, Inc.Utilization of biocompatible adhesive/sealant materials for securing surgical devices
US5569490 *Jun 2, 1995Oct 29, 1996Osaka Cement Co., Ltd.Tetracalcium phosphate-based materials and processes for their preparation
US5605713 *Feb 15, 1995Feb 25, 1997Boltong; Maria G.Process for the preparation of calcium phosphate cements and its application as bio-materials
US5607685 *Feb 8, 1995Mar 4, 1997Merck Patent Gesellschaft Mit Beschrankter HaftungProtracted-release adminstration forms containing clindamycin palmitate
US5652016 *Apr 2, 1996Jul 29, 1997Osaka Cement Co., Ltd.Tetracalcium phosphate-based materials and processes for their preparation
US5683461 *Dec 29, 1995Nov 4, 1997Etex CorporationSynthesis of reactive amorphous calcium phosphates
US5683496 *May 14, 1996Nov 4, 1997Norian CorporationStorage stable calcium phosphate cements
US5766669 *Oct 30, 1997Jun 16, 1998Millenium Biologix Inc.Sintering process for producing thin films of calcium phosphate entities
US5782971 *Mar 19, 1997Jul 21, 1998Norian CorporationCalcium phosphate cements comprising amorophous calcium phosphate
US5814681 *Oct 13, 1995Sep 29, 1998Kuraray Co., Ltd.Restorative composition for hard tissue and dispensing apparatus therefor
US5820632 *Apr 1, 1994Oct 13, 1998Norian CorporationPrepared calcium phosphate composition and method
US5891448 *Oct 29, 1996Apr 6, 1999American Dental Association Health FoundationControl of calcium fluoride formation in mouth rinses, dentifrices and gels
US5899939 *Jan 21, 1998May 4, 1999Osteotech, Inc.Bone-derived implant for load-supporting applications
US5954867 *Apr 25, 1997Sep 21, 1999American Dental Health Foundation AssociationSelf setting calcium phosphate cements and methods for preparing and using them
US5958430 *Feb 20, 1998Sep 28, 1999Battelle Memorial InstituteThin film composition with biological substance and method of making
US5964932 *Jul 7, 1998Oct 12, 1999Norian CorporationStorage stable calcium phosphate cements
US5976234 *Apr 25, 1997Nov 2, 1999American Dental Association Health FoundationSelf-setting calcium phosphate cements and methods for preparing and using them
US5993535 *Aug 27, 1998Nov 30, 1999Ngk Spark Plug Co., Ltd.Calcium phosphate cement and calcium phosphate cement composition
US6013591 *Jan 16, 1998Jan 11, 2000Massachusetts Institute Of TechnologyNanocrystalline apatites and composites, prostheses incorporating them, and method for their production
US6018095 *Jun 11, 1997Jan 25, 2000BiolandMethod for preparing an implantable composite material, resulting material, implant including said material, and kit therefor
US6027742 *Oct 16, 1996Feb 22, 2000Etex CorporationBioresorbable ceramic composites
US6117456 *Oct 16, 1996Sep 12, 2000Etex CorporationMethods and products related to the physical conversion of reactive amorphous calcium phosphate
US6118043 *Jun 7, 1995Sep 12, 2000Merck Patent Gesellschaft Mit Beschrankter HaftungBone replacement material with FGF
US6123731 *Feb 6, 1998Sep 26, 2000Osteotech, Inc.Osteoimplant and method for its manufacture
US6132463 *Oct 16, 1996Oct 17, 2000Etex CorporationCell seeding of ceramic compositions
US6149688 *Sep 29, 1997Nov 21, 2000Surgical Dynamics, Inc.Artificial bone graft implant
US6277149 *Jun 8, 1999Aug 21, 2001Osteotech, Inc.Ramp-shaped intervertebral implant
US6294041 *Apr 22, 1999Sep 25, 2001Osteotech, Inc.Method for an osteoimplant manufacture
US6294187 *Feb 23, 1999Sep 25, 2001Osteotech, Inc.Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same
US6323146 *Mar 19, 1998Nov 27, 2001Millenium Biologix, Inc.Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
US6340648 *Apr 13, 2000Jan 22, 2002Toshiba Ceramics Co., Ltd.Calcium phosphate porous sintered body and production thereof
US6379453 *Jul 14, 1999Apr 30, 2002Jiin-Huey ChernProcess for producing fast-setting, bioresorbable calcium phosphate cements
US6440444 *Jul 24, 2001Aug 27, 2002Osteotech, Inc.Load bearing osteoimplant and method of repairing bone using the same
US6478825 *Nov 28, 2001Nov 12, 2002Osteotech, Inc.Implant, method of making same and use of the implant for the treatment of bone defects
US6530955 *May 18, 2001Mar 11, 2003Osteotech, Inc.Ramp-shaped intervertebral implant
US6547866 *Oct 30, 2000Apr 15, 2003Howmedica Osteonics Corp.Porous calcium phosphate cement
US6569489 *May 19, 2000May 27, 2003Depuy Orthopaedics, Inc.Bioactive ceramic coating and method
US6585992 *Oct 4, 2001Jul 1, 2003Millenium Biologix, Inc.Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
US6616742 *Aug 30, 2001Sep 9, 2003Cana Lab CorporationProcess for preparing a paste from calcium phosphate cement
US6696073 *Aug 27, 2002Feb 24, 2004Osteotech, Inc.Shaped load-bearing osteoimplant and methods of making same
US6719989 *Sep 8, 2000Apr 13, 2004Pentax CorporationSustained release drug carrier, and method of manufacturing sustained release drug carrier
US6752831 *Dec 8, 2000Jun 22, 2004Osteotech, Inc.Biocompatible osteogenic band for repair of spinal disorders
US6793725 *Jan 23, 2002Sep 21, 2004Ada FoundationPremixed calcium phosphate cement pastes
US6808561 *Oct 16, 2001Oct 26, 2004University Of South CarolinaBiocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement
US6808585 *Oct 9, 2001Oct 26, 2004Osteotech, Inc.Osteogenic implants derived from bone
US6840995 *Dec 26, 2002Jan 11, 2005Calcitec, Inc.Process for producing fast-setting, bioresorbable calcium phosphate cements
US20020019635 *Oct 15, 2001Feb 14, 2002Wenstrom Richard F.Method for fixing a graft in a bone tunnel
US20020073894 *Oct 16, 2001Jun 20, 2002University Of South Carolina Research FoundationBiocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement
US20020137812 *Jan 23, 2002Sep 26, 2002American Dental Association Health FoundationPremixed calcium phosphate cement pastes
US20030019396 *Sep 9, 2002Jan 30, 2003Howmedica Osteonics Corp.Porous calcium phosphate cement
US20030031698 *Jan 31, 2001Feb 13, 2003Roeder Ryan K.Composite biomaterial including anisometric calcium phosphate reinforcement particles and related methods
US20030039676 *Aug 27, 2002Feb 27, 2003Boyce Todd M.Shaped load-bearing osteoimplant and methods of making same
US20030055512 *May 21, 2001Mar 20, 2003Genin Francois Y.Calcium based neutral and bioresorbable bone graft
US20030078317 *Aug 30, 2001Apr 24, 2003Jiin-Huey LinProcess for preparing a paste from calcium phosphate cement
US20030121450 *Dec 26, 2002Jul 3, 2003Jiin-Huey Chern LinProcess for producing fast-setting, bioresorbable calcium phosphate cements
US20030167093 *Mar 1, 2002Sep 4, 2003American Dental Association Health FoundationSelf-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates
US20030216777 *May 16, 2002Nov 20, 2003Yin-Chun TienMethod of enhancing healing of interfacial gap between bone and tendon or ligament
US20040003757 *Jun 27, 2003Jan 8, 2004Cana Lab CorporationTetracalcium phosphate (TTCP) having calcium phosphate whisker on surface
US20040022825 *Dec 20, 2002Feb 5, 2004Lagow Richard J.Calcium phosphate bone replacement materials and methods of use thereof
US20040031420 *Apr 16, 2003Feb 19, 2004Lin Jiin-Huey ChernCalcium phosphate cement, use and preparation thereof
US20040076685 *Jul 11, 2003Apr 22, 2004Merck Patent GmbhMethod of preparing porous calcium phosphate morsels and granules via gelatin processing
US20040137032 *Mar 11, 2003Jul 15, 2004Wang Francis W.Combinations of calcium phosphates, bone growth factors, and pore-forming additives as osteoconductive and osteoinductive composite bone grafts
US20040175320 *Feb 6, 2004Sep 9, 2004Calcitec, Inc.Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same
US20040180091 *Mar 13, 2003Sep 16, 2004Chang-Yi LinCarbonated hydroxyapatite-based microspherical composites for biomedical uses
US20040185181 *Feb 6, 2004Sep 23, 2004Pentax CorporationPorous sintered body of calcium phosphate-based ceramic and method for producing same
US20040186481 *Sep 29, 2003Sep 23, 2004Cana Lab CorporationMethod for forming a hardened cement in a bone cavity
US20050008759 *Jul 11, 2003Jan 13, 2005Li NieGrain protein-based formulations and methods of using same
US20050069479 *Sep 14, 2004Mar 31, 2005Calcitec, Inc.Method of increasing working time of tetracalcium phosphate cement paste
US20050076813 *Sep 17, 2004Apr 14, 2005Calcitec, Inc.Process for producing fast-setting, bioresorbable calcium phosphate cements
US20050184417 *Feb 19, 2004Aug 25, 2005Cana Lab CorporationMethod for making a porous calcium phosphate article
US20050186354 *Mar 3, 2005Aug 25, 2005Lin Jiin-Huey C.Method for making a porous calcium phosphate article
USRE33161 *Mar 2, 1988Feb 6, 1990American Dental Association Health FoundationCombinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements
USRE33221 *May 18, 1987May 22, 1990American Dental Association Health FoundationDental restorative cement pastes
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US8481065Dec 16, 2010Jul 9, 2013Howmedica Osteonics Corp.Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same
US8722073Jun 6, 2013May 13, 2014Howmedica Osteonics Corp.Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same
US20110152195 *Dec 16, 2010Jun 23, 2011Howmedica Osteonics Corp.Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same
US20160199532 *Mar 24, 2016Jul 14, 2016The University Of ToledoInjectable, Biodegradable Bone Cements and Methods of Making and Using Same
US20160199533 *Mar 23, 2016Jul 14, 2016The University Of ToledoInjectable, Biodegradable Bone Cements and Methods of Making and Using Same
EP2489346A1 *Jan 26, 2011Aug 22, 2012NanotecMARIN GmbHFood supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
WO2012101218A1 *Jan 26, 2012Aug 2, 2012Nanotecmarin GmbhFood supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
Classifications
U.S. Classification424/602, 433/217.1
International ClassificationA61L24/00, C04B28/34, A61K6/033, A61L27/50, C04B12/02, A61L24/02, A61L27/12, C04B14/36, A61K33/42, A61C5/00, A61C5/06
Cooperative ClassificationY10T428/2991, Y10T428/2993, A61L27/12, C04B28/344, C04B14/366, A61K6/0643, A61K6/0008, A61K6/0067, A61C5/062, C04B28/346, A61L24/001, C04B2111/00836, C04B28/34, A61K33/42, A61L24/02, A61K6/033, C04B12/025, A61L27/50, C04B12/02
European ClassificationC04B12/02D, C04B28/34H, A61L24/02, C04B14/36P, A61L27/50, C04B28/34, A61L24/00H, C04B28/34K, C04B12/02, A61L27/12, A61K6/033, A61C5/06A, A61K33/42
Legal Events
DateCodeEventDescription
Aug 19, 2005ASAssignment
Owner name: CANA LAB CORPORATION, TAIWAN
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIN, JIIN-HUEY CHERN;JU, CHIEN-PING;CHEN, WEN-CHENG;REEL/FRAME:016901/0974;SIGNING DATES FROM 20030817 TO 20030820
Owner name: CALCITEC, INC., TEXAS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CANA LAB CORPORATION;REEL/FRAME:016901/0966
Effective date: 20040314